Latest filing published 16 Jun 2014 for CELGENE CORP /DE/.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Rodman L. Drake across 12 companies, led by Crystal River Capital, Inc., Celgene Corp /DE/ and Brookfield Total Return Fund Inc. Over a trading history stretching from 3 January 2006 to 15 June 2014, the count stands at 161 filings.
The open-market side counts 87 purchases for €781k alongside 16 sales for €128k. The totals exclude 1 filing filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 33 share grants and 22 option exercises. In 2014 alone, the filings show 2 purchases and 1 sale.
Half of the purchases are above €4,687 and half below.
The newest entry dates from 16 June 2014: an option exercise, in Celgene Corp /DE/. The last purchase on record was published on 5 June 2014, which is 4,523 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 158 declarations